EFFECT OF AN UPTAKE INHIBITOR ON SEROTONIN METABOLISM IN RAT-BRAIN - STUDIES WITH 3-PARA-TRIFLUOROMETHYLPHENOXY)-N-METHYL-3-PHENYLPROPYLAMINE (LILLY 110140)
EFFECT OF AN UPTAKE INHIBITOR ON SEROTONIN METABOLISM IN RAT-BRAIN - STUDIES WITH 3-PARA-TRIFLUOROMETHYLPHENOXY)-N-METHYL-3-PHENYLPROPYLAMINE (LILLY 110140)
复制标题
DOI:
10.1016/s0024-3205(74)80012-3
复制
发表时间:
1974-01-01
期刊:
影响因子:
6.1
通讯作者:
MOLLOY, BB
中科院分区:
文献类型:
--
作者:
FULLER, RW;PERRY, KW;MOLLOY, BB
Lilly 110140 is an inhibitor of serotonin uptake by brain synaptosomes. In rats, it had no effect on brain levels of tryptophan, serotonin, dopamine, or norepinephrine, but it decreased 5-hydroxyindoleacetic acid (5HIAA) levels. The decrease in 5HIAA levels was dose-related over a 1–20 mg/kg i.p. dose range and persisted for at least 24 hrs after a 10 mg/kg dose of 110140. The decline in 5HIAA levels occurred mostly in the cerebral hemispheres and midbrain and apparently resulted from a reduced turnover of serotonin. Reduced turnover was indicated by a decreased rate of fall in brain serotonin levels after p-chlorophenylalamine was given to inhibit serotonin synthesis. Turnover rates calculated from the rate of 5HIAA accumulation in brain after probenecid injection were 0.18 μg/g/hr in control rats and 0.066 μg/g/hr in 110140-treated rats. The decline in serotonin turnover presumably is a compensatory mechanism occurring when receptor sites are overstimulated due to blockade of the reuptake (inactivation) of serotonin at the nerve synapse.